Skip to main content
. 2021 Jun 19;90:153635. doi: 10.1016/j.phymed.2021.153635

Fig. 8.

Fig 8

RDN relieved LPS-induced lung injury by inhibition of NETs formation through MAPK pathway. RDN and their compounds inhibit the phosphorylation of ERK1/2-related NETs formation, thus ameliorating LPS-induced acute lung injury.